Neidio i'r cynnwys
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Iaith
Pob Maes
Teitl
Awdur
Pwnc
Rhif Galw
ISBN/ISSN
Tag
Canfod
Uwch
Effects of interleukin-1 polym...
Dyfynnu hwn
Anfonwch hwn fel neges destun
E-bostio hwn
Argraffu
Allforio Cofnod
Allforio i RefWorks
Allforio i EndNoteWeb
Allforio i EndNote
Permanent link
Effects of interleukin-1 polymorphisms on susceptibility and clinical characteristics of British caucasian rheumatoid arthritis patients
Manylion Llyfryddiaeth
Prif Awduron:
Harrison, P
,
Chapman, K
,
Pointon, J
,
Farrar, C
,
Harin, A
,
Jess, C
,
Wordsworth, B
Fformat:
Conference item
Cyhoeddwyd:
2008
Daliadau
Disgrifiad
Eitemau Tebyg
Dangos Staff
Eitemau Tebyg
MHC2TA promoter polymorphism (-168*G/A, rs3087456) is not associated with susceptibility to rheumatoid arthritis in British Caucasian rheumatoid arthritis patients.
gan: Harrison, P, et al.
Cyhoeddwyd: (2007)
Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients.
gan: Harrison, P, et al.
Cyhoeddwyd: (2006)
HLA-DRB1 influence on anti-TNF treatment in British Caucasian rheumatoid arthritis patients
gan: Harrison, P, et al.
Cyhoeddwyd: (2006)
The PTPN22 R620W polymorphism - Effects on susceptibility and clinical features on British Caucasian rheumatoid arthritis patients.
gan: Harrison, P, et al.
Cyhoeddwyd: (2005)
Polymorphism in codon 17 of the CTLA-4 gene (+49 A/G) is not associated with susceptibility to rheumatoid arthritis in British Caucasians.
gan: Milicic, A, et al.
Cyhoeddwyd: (2001)